Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery
PHASE2
This study is a prospective, randomized, controlled, open, phase II, multic...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma
PHASE2
This is a single-arm, multicenter, exploratory clinical study evaluating th...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University